PharmacoEconomics & Outcomes News


ISSN: 1173-5503        年代:2004
当前卷期:Volume &NA;  issue 461     [ 查看所有卷期 ]

年代:2004
 
     Volume &NA;  issue 444   
     Volume &NA;  issue 445   
     Volume &NA;  issue 446   
     Volume &NA;  issue 447   
     Volume &NA;  issue 448   
     Volume &NA;  issue 449   
     Volume &NA;  issue 450   
     Volume &NA;  issue 451   
     Volume &NA;  issue 452   
     Volume &NA;  issue 453   
     Volume &NA;  issue 454   
     Volume &NA;  issue 455   
     Volume &NA;  issue 456   
     Volume &NA;  issue 457   
     Volume &NA;  issue 458   
     Volume &NA;  issue 459   
     Volume &NA;  issue 460   
     Volume &NA;  issue 461
     Volume &NA;  issue 462   
     Volume &NA;  issue 463   
     Volume &NA;  issue 464   
     Volume &NA;  issue 465   
     Volume &NA;  issue 466   
     Volume &NA;  issue 467   
     Volume &NA;  issue 468   
     Volume &NA;  issue 4444   
1. The US FDA has been urged to produce better guidance for emerging drug/device combination product categories,
  PharmacoEconomics & Outcomes News,   Volume  &NA;,   Issue  461,   2004,   Page  2-2

&NA;,  

Preview

2. Preventing MTCT of HIV infections still a health priority
  PharmacoEconomics & Outcomes News,   Volume  &NA;,   Issue  461,   2004,   Page  3-4

&NA;,  

Preview

3. Opioid analgesic guidelines deserve praise, says US physician
  PharmacoEconomics & Outcomes News,   Volume  &NA;,   Issue  461,   2004,   Page  4-4

&NA;,  

Preview

4. Chemotherapy assay recommendations published, refuted
  PharmacoEconomics & Outcomes News,   Volume  &NA;,   Issue  461,   2004,   Page  5-5

&NA;,  

Preview

5. US FDA finds US generics less costly than Canadian counterparts
  PharmacoEconomics & Outcomes News,   Volume  &NA;,   Issue  461,   2004,   Page  6-6

&NA;,  

Preview

6. Combination therapy potentially superior in variceal haemorrhage
  PharmacoEconomics & Outcomes News,   Volume  &NA;,   Issue  461,   2004,   Page  7-7

&NA;,  

Preview

7. High-dose antipsychotic use prevalent in East Asia
  PharmacoEconomics & Outcomes News,   Volume  &NA;,   Issue  461,   2004,   Page  8-8

&NA;,  

Preview

8. The stroke-reducing effect of losartan in patients with hypertension and LVH*could have a"major public health impact"in the EU,
  PharmacoEconomics & Outcomes News,   Volume  &NA;,   Issue  461,   2004,   Page  9-9

&NA;,  

Preview

9. Antipsychotic polypharmacy prevalent in East Asia
  PharmacoEconomics & Outcomes News,   Volume  &NA;,   Issue  461,   2004,   Page  10-10

&NA;,  

Preview

10. GenoMed, Inc., a next generation disease management (DM) company, has announced that it can guarantee lower healthcare costs for large US corporations such as General Motors.
  PharmacoEconomics & Outcomes News,   Volume  &NA;,   Issue  461,   2004,   Page  11-11

&NA;,  

Preview

首页 上一页 下一页 尾页 第1页 共10条